What is new in the blood bank for trauma resuscitation

Roman Dudaryk, Aaron S. Hess, Albert J. Varon, John R. Hess

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: The aim of the present review was to describe recent changes in blood banking thinking, practice, and products that affect trauma care.

RECENT FINDINGS: Prompt balanced hemostatic resuscitation of major hemorrhage from trauma improves outcome and reduces blood use. New blood processes and products can help deliver appropriate doses of procoagulant plasma and platelets quicker and more safely. New processes include holding larger inventories of thawed plasma with risk of wastage and rapid plasma thawers. New products in the blood bank include group A or group A low-titer B thawed plasma and AB or A liquid (never-frozen) plasma for resuscitation, prepooled cultured whole blood–derived platelets in plasma, and prepooled cryoprecipitate in varying pool sizes. Single-donor apheresis or pooled whole blood–derived platelets in additive solution, designed to reduce plasma-related transfusion reactions, are also increasingly available but are not an appropriate blood component for hemorrhage control resuscitation because they reduce the total amount of administered plasma coagulation factors by 10%.

SUMMARY: Early initiation of balanced massive transfusion protocols leading to hemostatic resuscitation is lifesaving. Changing blood product availability and composition will lead to higher complexity of massive transfusion. It is critical that anesthesiologists understand the composition of the available new blood products to use them correctly.

Original languageEnglish
JournalCurrent Opinion in Anaesthesiology
DOIs
StateAccepted/In press - Dec 12 2014

Fingerprint

Blood Banks
Resuscitation
Wounds and Injuries
Blood Platelets
Hemostatics
Hemorrhage
Blood Component Removal
Blood Coagulation Factors
Tissue Donors
Equipment and Supplies

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

What is new in the blood bank for trauma resuscitation. / Dudaryk, Roman; Hess, Aaron S.; Varon, Albert J.; Hess, John R.

In: Current Opinion in Anaesthesiology, 12.12.2014.

Research output: Contribution to journalArticle

@article{b6436f85af7e4ee785949b32762e3419,
title = "What is new in the blood bank for trauma resuscitation",
abstract = "PURPOSE OF REVIEW: The aim of the present review was to describe recent changes in blood banking thinking, practice, and products that affect trauma care.RECENT FINDINGS: Prompt balanced hemostatic resuscitation of major hemorrhage from trauma improves outcome and reduces blood use. New blood processes and products can help deliver appropriate doses of procoagulant plasma and platelets quicker and more safely. New processes include holding larger inventories of thawed plasma with risk of wastage and rapid plasma thawers. New products in the blood bank include group A or group A low-titer B thawed plasma and AB or A liquid (never-frozen) plasma for resuscitation, prepooled cultured whole blood–derived platelets in plasma, and prepooled cryoprecipitate in varying pool sizes. Single-donor apheresis or pooled whole blood–derived platelets in additive solution, designed to reduce plasma-related transfusion reactions, are also increasingly available but are not an appropriate blood component for hemorrhage control resuscitation because they reduce the total amount of administered plasma coagulation factors by 10{\%}.SUMMARY: Early initiation of balanced massive transfusion protocols leading to hemostatic resuscitation is lifesaving. Changing blood product availability and composition will lead to higher complexity of massive transfusion. It is critical that anesthesiologists understand the composition of the available new blood products to use them correctly.",
author = "Roman Dudaryk and Hess, {Aaron S.} and Varon, {Albert J.} and Hess, {John R.}",
year = "2014",
month = "12",
day = "12",
doi = "10.1097/ACO.0000000000000156",
language = "English",
journal = "Current Opinion in Anaesthesiology",
issn = "0952-7907",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - What is new in the blood bank for trauma resuscitation

AU - Dudaryk, Roman

AU - Hess, Aaron S.

AU - Varon, Albert J.

AU - Hess, John R.

PY - 2014/12/12

Y1 - 2014/12/12

N2 - PURPOSE OF REVIEW: The aim of the present review was to describe recent changes in blood banking thinking, practice, and products that affect trauma care.RECENT FINDINGS: Prompt balanced hemostatic resuscitation of major hemorrhage from trauma improves outcome and reduces blood use. New blood processes and products can help deliver appropriate doses of procoagulant plasma and platelets quicker and more safely. New processes include holding larger inventories of thawed plasma with risk of wastage and rapid plasma thawers. New products in the blood bank include group A or group A low-titer B thawed plasma and AB or A liquid (never-frozen) plasma for resuscitation, prepooled cultured whole blood–derived platelets in plasma, and prepooled cryoprecipitate in varying pool sizes. Single-donor apheresis or pooled whole blood–derived platelets in additive solution, designed to reduce plasma-related transfusion reactions, are also increasingly available but are not an appropriate blood component for hemorrhage control resuscitation because they reduce the total amount of administered plasma coagulation factors by 10%.SUMMARY: Early initiation of balanced massive transfusion protocols leading to hemostatic resuscitation is lifesaving. Changing blood product availability and composition will lead to higher complexity of massive transfusion. It is critical that anesthesiologists understand the composition of the available new blood products to use them correctly.

AB - PURPOSE OF REVIEW: The aim of the present review was to describe recent changes in blood banking thinking, practice, and products that affect trauma care.RECENT FINDINGS: Prompt balanced hemostatic resuscitation of major hemorrhage from trauma improves outcome and reduces blood use. New blood processes and products can help deliver appropriate doses of procoagulant plasma and platelets quicker and more safely. New processes include holding larger inventories of thawed plasma with risk of wastage and rapid plasma thawers. New products in the blood bank include group A or group A low-titer B thawed plasma and AB or A liquid (never-frozen) plasma for resuscitation, prepooled cultured whole blood–derived platelets in plasma, and prepooled cryoprecipitate in varying pool sizes. Single-donor apheresis or pooled whole blood–derived platelets in additive solution, designed to reduce plasma-related transfusion reactions, are also increasingly available but are not an appropriate blood component for hemorrhage control resuscitation because they reduce the total amount of administered plasma coagulation factors by 10%.SUMMARY: Early initiation of balanced massive transfusion protocols leading to hemostatic resuscitation is lifesaving. Changing blood product availability and composition will lead to higher complexity of massive transfusion. It is critical that anesthesiologists understand the composition of the available new blood products to use them correctly.

UR - http://www.scopus.com/inward/record.url?scp=84918795761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84918795761&partnerID=8YFLogxK

U2 - 10.1097/ACO.0000000000000156

DO - 10.1097/ACO.0000000000000156

M3 - Article

C2 - 25500691

AN - SCOPUS:84926408862

JO - Current Opinion in Anaesthesiology

JF - Current Opinion in Anaesthesiology

SN - 0952-7907

ER -